Dmitry Genis, CEO and Founder

Mr. Genis has successfully guided ASINEX from being a start-up company of 3 employees to becoming a well-recognized name in the drug discovery sector, currently employing 80 staff globally. Mr. Genis has 25+ years of experience in the areas of research, development, marketing, strategy and operations.

Mark Parisi, Executive Director

Mr. Parisi has more than 20 years of international business experience and was instrumental in the founding and development of the company’s presence in the United States. He is responsible for the creation of multiple start-up companies and has over 16 years of experience in the life science field.

Ludmila Sadovenko, Director of Marketing Strategy

Ms. Sadovenko is a world-wide expert in the biotechnology industry with strength of special focus on building customer and vendor relationships. Ms Sadovenko joined ASINEX in 1995 and has held a number of roles of increasing responsibility at Asinex.

Roman Kombarov, Head of Business Development

Dr. Kombarov has more than 15 years of industry experience in both management and research positions. He has lead cross-functional research teams that have advanced the discovery and lead optimization of small molecule programs in oncology, CNS, and infectious disease in collaboration with external partners.

Ramon Jimenez‐Moreno, Head of Pre-clinical Biology

Dr. Jimenez-Moreno has extensive experience in assay set-up and validation with special interest in aging, cancer, infection, and neuromuscular diseases.

Shingo Ota, Corporate Officer, Asinex Japan

Mr. Ota joined ASINEX in 2002 bringing his multi-year experience in sourcing and distributing screening collections, building blocks and fine chemicals for the Japanese life science industry. At ASINEX, Mr. Ota focuses on developing outstanding customer service and building lasting relationships with Japan-based pharmaceutical and agrochemical companies.